The Patient Activation Measure-13 (PAM-13) in an oncology patient population: psychometric properties and dimensionality evaluation
- PMID: 38764032
- PMCID: PMC11103863
- DOI: 10.1186/s12955-024-02255-w
The Patient Activation Measure-13 (PAM-13) in an oncology patient population: psychometric properties and dimensionality evaluation
Abstract
Background: Accurate assessment and enhancement of health-related skills among oncology patients are pivotal for optimizing cancer care. The Patient Activation Measure (PAM-13), a questionnaire designed to reflect an individual's knowledge, skills, and confidence in self-healthcare management, has been validated across diverse countries and settings. Concerns have been raised regarding the cross-situational applicability, as patients with specific diseases and cultural backgrounds interpret questionnaire items differently. This study aimed to examine the structural validity and psychometric properties of the PAM-13 in an oncological patient cohort.
Methods: Baseline data from a longitudinal non-randomized controlled study involving cancer out-patients (n = 1,125) from Comprehensive Cancer Centres in Southern Germany were analysed. The German version of the PAM-13 was employed. With classical test and item response theory methods data quality, reliability, convergent and structural validity, as well as psychometric properties were assessed. Exploratory (EFA) and confirmatory factor analyses (CFA) were employed to investigate the postulated unidimensionality of the underlying construct. With a partial credit model (PCM) we examined item fit, targeting, local independence and differential item functioning.
Results: Participants were predominantly female (73.0%) with a breast cancer diagnosis (41.3%). While items were generally well-accepted, ceiling effects were observed and a high mean PAM-13 score (69.7, SD = 14.2) was noted, potentially compromising responsiveness to interventions. Reliability was adequate (Cronbach's α = 0.81), person and item separation reliability were good to excellent (0.81 and 0.99, respectively). Explorations of the unidimensionality of the construct (EFA, CFA, PCM) yielded inconclusive results, hinting towards a two-factor solution. Item difficulty rankings deviated from the original. No differential item functioning was identified, and local independence was confirmed.
Conclusions: While the PAM-13 serves as a valuable instrument for comprehending and promoting health-related skills in cancer patients, the identification of ceiling effects, disordered item-difficulty rankings, and inconclusive findings regarding unidimensionality contribute to the expanding body of evidence, emphasizing the dependency of PAM-13's validity and reliability on distinctive characteristics within the population under investigation. Future research should prioritize refining or adding PAM-13 items to better capture the specific health-related challenges within diverse populations, paving the way for more effective patient engagement strategies in oncology.
Trial registration number: DRKS00021779.
Keywords: Cancer care; Confirmatory factor analysis; Exploratory factor analysis; Item response theory; PAM-13; Partial credit model; Patient activation measure; Psychometric evaluation.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Is the Patient Activation Measure a valid measure of osteoarthritis self-management attitudes and capabilities? Results of a Rasch analysis.Health Qual Life Outcomes. 2020 May 5;18(1):121. doi: 10.1186/s12955-020-01364-6. Health Qual Life Outcomes. 2020. PMID: 32370751 Free PMC article.
-
Measuring patient activation: the utility of the Patient Activation Measure administered in an interview setting.Qual Life Res. 2024 May;33(5):1389-1400. doi: 10.1007/s11136-024-03614-2. Epub 2024 Feb 22. Qual Life Res. 2024. PMID: 38388807 Free PMC article.
-
Validation of the patient activation measure in patients at discharge from hospitals and at distance from hospital care in Sweden.BMC Public Health. 2019 Dec 19;19(1):1701. doi: 10.1186/s12889-019-8025-1. BMC Public Health. 2019. PMID: 31856796 Free PMC article.
-
A Systematic Review of the Reliability and Validity of the Patient Activation Measure Tool.Healthcare (Basel). 2024 May 24;12(11):1079. doi: 10.3390/healthcare12111079. Healthcare (Basel). 2024. PMID: 38891154 Free PMC article. Review.
-
Measuring future time perspective across adulthood: development and evaluation of a brief multidimensional questionnaire.Gerontologist. 2014 Dec;54(6):1075-88. doi: 10.1093/geront/gnu076. Epub 2014 Jul 25. Gerontologist. 2014. PMID: 25063938 Free PMC article. Review.
Cited by
-
Patient Activation and Shared Decision-Making Among Hispanics/Latinos With Metastatic Cancer: A Qualitative Study.Psychooncology. 2025 Apr;34(4):e70145. doi: 10.1002/pon.70145. Psychooncology. 2025. PMID: 40195049 Free PMC article.
-
The Extent to Which Artificial Intelligence Can Help Fulfill Metastatic Breast Cancer Patient Healthcare Needs: A Mixed-Methods Study.Curr Oncol. 2025 Mar 2;32(3):145. doi: 10.3390/curroncol32030145. Curr Oncol. 2025. PMID: 40136349 Free PMC article.
References
-
- National Cancer Institute Cancer Statistics. 2020 [ https://www.cancer.gov/about-cancer/understanding/statistics.
-
- Institute of Medicine Cancer Care for the Whole PatientAdler NE, Page AEK, editors. Meeting Psychosocial Health needs. Washington, DC: The National Academies; 2008. p. 454. - PubMed
-
- Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1998;1(1):2–4. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous